Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
42.29 USD | -0.05% | -0.14% | -0.38% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.38% | 7.71B | |
+7.30% | 113B | |
+11.14% | 106B | |
+0.32% | 22.27B | |
-11.95% | 22.22B | |
-5.99% | 19.43B | |
-37.85% | 17.87B | |
-6.32% | 17.24B | |
+6.89% | 14.29B | |
+35.16% | 12.52B |
- Stock Market
- Equities
- CERE Stock
- News Cerevel Therapeutics Holdings, Inc.
- Goldman Sachs Adjusts Price Target on Cerevel Therapeutics to $30 From $31, Keeps Neutral Rating